Last edition
News about "IQVIA market data"
Alembic Pharmaceuticals Announces US FDA Final Approval for Tretinoin Cream
Alembic Pharmaceuticals has received US Food and Drug Administration (FDA) final approval for Tretinoin Cream USP, 0.05 percent, a generic version of Bausch Health’s Retin-A Cream.
IQVIA Market Data | 12/06/2026 | By News Bureau | 113
Alembic Pharma Receives USFDA Approval for Haloperidol Tablets
Alembic Pharmaceuticals has received final US FDA approval for Haloperidol Tablets USP in multiple strengths. The medication is indicated for the management of psychotic disorders and the treatment of tics and vocal utterances associated with Tourette’s Disorder in both children and adults, expanding Alembic’s US CNS product portfolio.
IQVIA Market Data | 05/06/2026 | By News Bureau | 111
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy